extranodal NK/T-cell lymphoma
Conditions
Interventions
None listed
Sponsors
Jichi Medical University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Adult patients with extranodal NK/T-cell lymphoma (ENKL). 2. Patients who underwent treatment with autologous or allogeneic hematopoietic stem cell transplantation. Study design: A comprehensive literature search will be conducted in PubMed and Embase according to the search strategy described below (see the "Other" section). No restrictions will be applied with respect to language, country of origin, publication date, study design (prospective or retrospective), single-center or multicenter setting, or registry-based studies. Eligible studies must include at least five patients with ENKL. If a study includes patients with other diseases, only data specific to ENKL patients will be extracted and analyzed.
Exclusion criteria
Exclusion criteria: 1.Duplicate publications 2.Conference proceedings
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Overall survival | — |
Secondary
| Measure | Time frame |
|---|---|
| Progression free survival, disease free survival, relapse free survival, rate of non-relapse mortality, relapse rate, rate of acute and chronic graft-versus-host disease | — |
Countries
Japan
Contacts
Public ContactRyutaro Tominaga
Jichi Medical University Hospital Division of Hematology
Outcome results
None listed